We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TXG market cap is 1.75B. The company's latest EPS is USD -2.1073 and P/E is -6.67.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 153.64M | 183.98M | 141.01M | 153.1M | 151.65M |
| Operating Income | -94.8M | -50.29M | -61.5M | -41.74M | -41.49M |
| Net Income | -92.99M | -48.95M | -59.95M | -37.9M | -35.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 245.89M | 298.85M | 491.15M | 516.41M | 618.73M |
| Operating Income | -30.57M | -534.14M | -52.25M | -167.94M | -260.43M |
| Net Income | -31.25M | -542.73M | -58.22M | -166M | -255.1M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 948.54M | 965.14M | 922.91M | 929.67M | 937.79M |
| Total Liabilities | 203.32M | 224.1M | 204.08M | 205.61M | 214.99M |
| Total Equity | 745.22M | 741.04M | 718.83M | 724.06M | 722.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 605.92M | 929.34M | 1.02B | 1.03B | 965.14M |
| Total Liabilities | 185.84M | 190.27M | 201.26M | 223.24M | 224.1M |
| Total Equity | 420.08M | 739.07M | 817.57M | 805.74M | 741.04M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -40.96M | -15.2M | -15.73M | -8.23M | 13.41M |
| Investing | 120.39M | 133.49M | 10.63M | 22.58M | 18.96M |
| Financing | 8.06M | 13.67M | 1.64M | 6.24M | 6.4M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 34.63M | -217.9M | -21.37M | -33.61M | -15.2M |
| Investing | -42.77M | -38.39M | -106.73M | -350.89M | 133.49M |
| Financing | 414.59M | 468.91M | 35.3M | 15.82M | 13.67M |
| Market Cap | 1.75B |
| Price to Earnings Ratio | -6.67 |
| Price to Sales Ratio | 2.75 |
| Price to Cash Ratio | 4.74 |
| Price to Book Ratio | 2.3 |
| Dividend Yield | - |
| Shares Outstanding | 121.05M |
| Average Volume (1 week) | 2.35M |
| Average Volume (1 Month) | 2.02M |
| 52 Week Change | -74.64% |
| 52 Week High | 57.90 |
| 52 Week Low | 12.95 |
| Spread (Intraday) | 1.47 (10.15%) |
| Company Name | 10x Genomics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.10xgenomics.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
